Ishita Drugs Board Meeting on May 30, 2026

Ishita Drugs & Industries Ltd has announced a Board Meeting scheduled for Saturday, May 30, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also discuss the Directors' Report, Corporate Governance Report, Management Discussion and Analysis Report, and the notice for the 33rd Annual General Meeting. Re-appointment of internal auditors and disclosure of director's interests are also on the agenda. The trading window is closed from April 1, 2026, until 48 hours after the announcement of the audited financial results.